P2 Capital Partners’s Pediatrix Medical MD Stock Holding History

P2 Capital Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,998,445	Closed	-$73.6M	–	21
2020 Q4	$73.6M	Sell	2,998,445 -1,103,555	-27%	-$20.7M	4.99%	13
2020 Q3	$66.8M	Hold	4,102,000	–	–	5.23%	12
2020 Q2	$70.1M	Buy	4,102,000 +201,975	+5%	+$2.99M	5.86%	9
2020 Q1	$45.4M	Hold	3,900,025	–	–	5.43%	10
2019 Q4	$108M	Buy	3,900,025 +1,150,025	+42%	+$28.8M	7.95%	5
2019 Q3	$62.2M	Hold	2,750,000	–	–	4.2%	10
2019 Q2	$69.4M	Buy	2,750,000 +1,353,111	+97%	+$36.3M	5.3%	9
2019 Q1	$38M	Buy	1,396,889 +239,221	+21%	+$8.02M	3.15%	14
2018 Q4	$38.2M	Sell	1,157,668 -642,332	-36%	-$25.8M	3.85%	13
2018 Q3	$84M	Buy	1,800,000 +3,871	+0.2%	+$178K	7.54%	4
2018 Q2	$77.7M	Buy	+1,796,129	New	+$86.1M	7.89%	4

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

P2 Capital Partners's MD Position: Q1 2021 in Review

P2 Capital Partners sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 2,998,445 shares — an estimated $73.6M sold.

P2 Capital Partners first reported a position in MD in Q2 2018 and held it in 11 quarters. The position peaked at $108M in Q4 2019. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

P2 Capital Partners reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
P2 Capital Partners sold 2,998,445 Pediatrix Medical shares in Q1 2021, an estimated $73.6M.
P2 Capital Partners first reported a position in Pediatrix Medical in Q2 2018 and held it in 11 quarters.
P2 Capital Partners's Pediatrix Medical position peaked at $108M in Q4 2019.
207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on P2 Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.